X4 Pharmaceuticals (XFOR) Other Non-Current Assets (2017 - 2025)

X4 Pharmaceuticals' Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $692000.0 for Q4 2025.

• Quarterly Other Non-Current Assets fell 66.73% year-over-year to $692000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $692000.0 (down 66.73% YoY) and the FY2025 annual result came in at $692000.0, down 66.73% from the prior year.
• Other Non-Current Assets was $692000.0 for Q4 2025 at X4 Pharmaceuticals, down from $2.0 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $3.0 million in Q1 2025 and bottomed at $692000.0 in Q4 2025.
• A 5-year average of $1.7 million and a median of $1.8 million in 2021 frame the typical range for Other Non-Current Assets.
• Peak annual rise in Other Non-Current Assets reached 101.94% in 2025, while the deepest fall reached 66.73% in 2025.
• X4 Pharmaceuticals' Other Non-Current Assets stood at $1.7 million in 2021, then retreated by 28.9% to $1.2 million in 2022, then advanced by 17.22% to $1.4 million in 2023, then soared by 44.85% to $2.1 million in 2024, then slumped by 66.73% to $692000.0 in 2025.
• Business Quant data shows XFOR's Other Non-Current Assets at $692000.0 in Q4 2025, $2.0 million in Q3 2025, and $2.4 million in Q2 2025.